Skip to main content
logo
Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia flag Australia · Delayed Price · Currency is AUD
2.100
+0.010 (0.48%)
Sep 17, 2026, 4:10 PM AEST

Clarity Pharmaceuticals Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
10.5310.539.4611.519.86.46
Revenue Growth
-0.51%11.24%-17.76%17.41%51.74%102.07%
Gross Profit
10.5310.539.4611.519.86.46
Operating Income
-108.38-108.38-69.09-44.21-26.36-17.05
Net Income
-107.24-107.24-64.3-42.32-24.6-23.75
Earnings Per Share
-0.29-0.29-0.20-0.15-0.10-0.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
178.25178.2584.12136.5165.0192.34
Net Cash Growth
-21.21%111.91%-38.38%109.96%-29.59%387.54%
Net Cash Per Share
0.480.480.260.500.250.37
Cash & Investments
178.25178.2584.12136.5165.0192.34

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-92.55-92.55-54.77-43.24-27.5-13.31
Capital Expenditures
-0.31-0.31-0.18-0.5-0.05-0.21
Free Cash Flow
-92.85-92.85-54.95-43.74-27.55-13.53
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-1029.61%-1029.61%-730.16%-384.24%-269.00%-263.94%
Pretax Margin
-1009.68%-1009.68%-675.05%-365.26%-249.98%-367.51%
Profit Margin
-1018.80%-1018.80%-679.45%-367.82%-251.03%-367.78%
FCF Margin
-882.10%-882.10%-580.71%-380.14%-281.07%-209.43%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
74.4375.8384.93146.7918.6220.37